X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (20) 20
humans (9) 9
index medicus (9) 9
chemotherapy (6) 6
immunotherapy (6) 6
animals (5) 5
cancer (5) 5
apoptosis (4) 4
cancer therapies (4) 4
female (4) 4
male (4) 4
medical research (4) 4
open-label (4) 4
adenocarcinoma - pathology (3) 3
cell biology (3) 3
cell line, tumor (3) 3
immunoglobulins (3) 3
medicine, experimental (3) 3
melanoma (3) 3
metastasis (3) 3
middle aged (3) 3
pd-1 blockade (3) 3
acquired-resistance (2) 2
adenocarcinoma (2) 2
adult (2) 2
advanced non-small cell lung cancer (2) 2
aged (2) 2
analysis (2) 2
angiogenesis (2) 2
antibodies, monoclonal - therapeutic use (2) 2
biomarker (2) 2
biomedicine (2) 2
biomedicine general (2) 2
breast-cancer (2) 2
cancer research (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
cardiology (2) 2
care and treatment (2) 2
colorectal cancer (2) 2
colorectal neoplasms - pathology (2) 2
curcumin (2) 2
drug combinations (2) 2
drugs (2) 2
expression (2) 2
hsp90 (2) 2
hypoxia (2) 2
hypoxia-inducible factor 1, alpha subunit - genetics (2) 2
immunoglobulin g - therapeutic use (2) 2
immunology (2) 2
ipilimumab (2) 2
kinases (2) 2
lung cancer (2) 2
lung neoplasms - pathology (2) 2
metastatic melanoma (2) 2
mice, nude (2) 2
neoplasm staging (2) 2
nf-kappa-b (2) 2
nivolumab (2) 2
ophthalmology (2) 2
pembrolizumab (2) 2
research (2) 2
signaling pathway (2) 2
survival (2) 2
treatment outcome (2) 2
trial (2) 2
tumor mutational burden (2) 2
vascular endothelial growth factor (2) 2
xenograft model antitumor assays (2) 2
acquired immune deficiency syndrome--aids (1) 1
actin cytoskeleton (1) 1
activated neutrophils (1) 1
adaptive resistance (1) 1
adenocarcinoma - blood supply (1) 1
adenocarcinoma - complications (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - therapy (1) 1
adenocarcinoma of lung (1) 1
adjuvant treatment (1) 1
administration, intravenous (1) 1
aged, 80 and over (1) 1
algorithm (1) 1
algorithms (1) 1
alveoli (1) 1
anemia (1) 1
anemia, hemolytic, autoimmune - complications (1) 1
anemia, hemolytic, autoimmune - mortality (1) 1
anemia, hemolytic, autoimmune - pathology (1) 1
anemia, hemolytic, autoimmune - therapy (1) 1
angiogenesis inhibitors - pharmacology (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
anti-pd-1 therapy (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - immunology (1) 1
antibodies, monoclonal, humanized - immunology (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
anticancer properties (1) 1
anticarcinogenic agents - therapeutic use (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S1247 - S1248
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S1247 - S1248
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 2617 - 2617
Journal Article
Clinical Lung Cancer, ISSN 1525-7304, 05/2019, Volume 20, Issue 3, pp. 143 - 147
There is a rising need for optimal biomarkers to better tailor treatments for patients with cancer in the era of immunotherapy. In addition to programmed... 
Biomarker | Advanced non-small cell lung cancer | PD-1 inhibitor | Neutrophil-to-lymphocyte ratio | Cost-effectiveness | SUPPRESSION | CHEMOTHERAPY | RESPONSES | PEMBROLIZUMAB | ACTIVATED NEUTROPHILS | ONCOLOGY | RESISTANCE | OUTCOMES | NIVOLUMAB | IPILIMUMAB | PROGRESSION
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 701 - 701
Journal Article
The Lancet Oncology, ISSN 1470-2045, 06/2019, Volume 20, Issue 6, pp. 837 - 848
VEGF promotes an immunosuppressive microenvironment and contributes to immune checkpoint inhibitor resistance in cancer. We aimed to assess the activity of the... 
PAZOPANIB | ONCOLOGY | TISSUE SARCOMA | OPEN-LABEL | POINT | CANCER | IPILIMUMAB | Tyrosine | Complications and side effects | Medical research | Care and treatment | Endothelial growth factors | Sarcoma | Analysis | Medicine, Experimental | Axitinib | Product development
Journal Article
BMJ Case Reports, ISSN 1757-790X, 2018, Volume 2018, p. bcr-2017-221801
We describe a rare case of severe autoimmune haemolytic anaemia (AIHA) in the setting of underlying chronic lymphocytic leukaemia receiving intravenous... 
Adenocarcinoma - pathology | Adenocarcinoma of Lung | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Leukemia, Lymphocytic, Chronic, B-Cell - complications | Neoplasm Recurrence, Local - pathology | Anemia, Hemolytic, Autoimmune - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - diagnostic imaging | Anemia, Hemolytic, Autoimmune - therapy | Fatal Outcome | Anemia, Hemolytic, Autoimmune - mortality | Solitary Pulmonary Nodule - pathology | Immunoglobulin G - therapeutic use | Anemia, Hemolytic, Autoimmune - complications | Positron-Emission Tomography - methods | Immunoglobulin G - administration & dosage | Adenocarcinoma - complications | Disease Progression | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Immunotherapy - adverse effects | Lung Neoplasms - complications | Administration, Intravenous | Immunoglobulins, Intravenous - therapeutic use | Antibodies, Monoclonal - administration & dosage | Nivolumab | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Lymphatic system | Immunoglobulins | Disease | Hematology | Laboratories | Anemia | Leukemia | Lung cancer | Melanoma | Metastasis | Cancer therapies | Skin cancer | Ostomy | Chemotherapy | Immunotherapy | Lymphomas | Apoptosis | Index Medicus
Journal Article
Molecular Carcinogenesis, ISSN 0899-1987, 10/2015, Volume 54, Issue 10, pp. 1147 - 1158
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e15233 - e15233
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 06/2018, Volume 101, Issue 2, pp. E24 - E24
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2012, Volume 131, Issue 4, pp. 956 - 969
Journal Article
Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. 2273 - 2273
Journal Article
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 07/2018, Volume 6, Issue 1, pp. 66 - 66
Background: Immune checkpoint inhibitors (CPIs) have shown promising results in many solid tumors. There are limited data on the safety and efficacy of these... 
HIV | Check point inhibitors | Small cell cancer | Immunotherapy | Neuroendocrine carcinoma | METASTATIC MELANOMA | LUNG-CANCER | RESERVOIR | ONCOLOGY | IMMUNOLOGY | T-CELLS | Antiretroviral drugs | Mutation | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e14636 - e14636
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 15, pp. e15102 - e15102
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 15, pp. 3015 - 3015
Conference Proceeding
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.